Peer Review History
Original SubmissionNovember 10, 2020 |
---|
PONE-D-20-35389 What is the quality of life among pregnant women with urinary incontinence? PLOS ONE Dear Dr. Mohd-Sidik, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Mar 11 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Peter F.W.M. Rosier, M.D. PhD Academic Editor PLOS ONE Additional Editor Comments: I think you have received very useful comments from the reviewers. I advise you to make good use of it. Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1.) Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2.) Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information. 3.) Please ensure you have thoroughly discussed any potential limitations of this study within the Discussion section, including the potential impact of confounding factors. 4.) Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This is an appropriate study to look at the quality of life in pregnant women with urinary incontinence in a local Malaysian community Major i) Introduction: The author to consider reviewing the definitions of the different types of UI and to address all different types of urinary incontinence. Then to consider in the methods section under in and exclusion criteria which types were excluded. ii)Methods: Author to clarify if the QOL questionnaire (ICIQ-LUTSQoL) was validated for their population and if so in which languages. The validation and local validation of their measure instrument (questionnaires) should reflect in the abstract and text methods section. iii) Results: Question to author is why author prefers to define and use the term urine “status” and not ”severity” of urinary incontinence? The severity is then categorized in no UI, slight and moderate incontinence where moderate includes severe urinary incontinence. If the author, consider changing the terminology it may contribute to easier reading. Page 8: Line 14: Consider replacing “status” with severity as well as in the Table1) Line 14: The presentation of the association is not clear to the reader. Can this be rephrased for more clarity to the reader? a) Page 9 Table 1: Suggest the author consider completing the table1 in total which may inform the reader better. Also indicate in the table Moderate and Severe incontinence is combined iv) Discussion: The author did not clearly address the strength and limitations of their study The author to consider addressing the above. Page 15 line 6: Is it true that damaged pelvic muscles causes urethral descent and mobilization? Can there be another explanation such as pelvic fascia or ligaments? Minor Page 8: line 9: Total of 180 respondents ……. severe UI. Consider reviewing as it makes out difficult reading Page 9 Line 4-6 (Grammar): The study …… assessing the QOL. Age …. Page 9 Line 4-6: Author may consider indicating if associations are associated with decreased or improved quality of life? Page 13 line 13: This study……. with moderate UI …. negative Qol. This sentence needs to be reviewed / rephrased to improve clarity to the reader Reviewer #2: First of all, thank you very much for give me the best opportunity for taking the reviewer role to review this manuscript. This is an interesting paper. The authors present a study to assess the risk factors and impact of UI on the QoL among incontinent pregnant women. A cross-sectional study design was used. I have read carefully and found that this study is very carefully created and developed. Although this study has scientific interest, some important aspect should be reviewed by the authors. I hope that my opinions will help shape your research article more precise and interesting. The followings are my comments; 1. The title of the study is not completely clear. The title indicates the dependent variable and samples. But, the independent variable and study design have not been included into the title. This makes the article sounded like a “review article” more than “research article”. Therefore, the authors should add the independent variable and study design in the title and rewrite the title. 2. The authors presented an appropriate and clear detail about the abstract section, but some point should add in topics as following: the authors please add sample size of the participants and duration of data collection. 3. The authors used appropriate key words. However, the authors please add “risk factors” as the key words of the study to guide the reader to easily find a good research title and attract to read it. 4. The introduction of the study is good written and shows the significance of the study. The author wrote the introduction in orderly manner beginning from relationship between pregnancy and urinary incontinence, definition, prevalence, risk factors, affect QoL, limitation of previous studies and aims of the study. Moreover, the authors presented a clear state of the aims of the study, but not showed the congruence with the aims of the study in the abstract section. 5. The authors used a cross-sectional study as a study design. It is an appropriate design in this study. The setting is clear. The authors presented a clear state of sample, inclusion and exclusion criteria, duration of data collection, sample size calculation and sampling method. Moreover, the protection of human subjects was clearly stated and presented the number of IRB (JKEUPM-2019-297) in the section. All subjects gave written informed consent before entering the study. 6. The authors presented a clear state of the measurements of the study which included the details, scoring, and classification of all measurements in the study (ICIQ-UI SF and ICIQ-LUTSQoL). However, what is the reliability of ICIQ-UI SF and ICIQ-LUTSQoL in the study? The authors please state the reliability of all measurements in the study. 7. In the results section, the authors presented all data both text and tables. At the beginning, the authors detailed about the demographic of the pregnant women with and without UI during pregnancy which presented in Table 1. Consequently, the authors used three tables to present the results of the study as following: Table 2 to present the scores of QoL, Table 3 to present seven domains of QoL with significant sociodemographics and Types of UI, and Table 4 to present the significant predictors of QoL among pregnant women. Therefore, the authors used appropriate number and running head title of the tables to report the significant findings, these may help the readers more clearly understand. 8. The discussion had been good written which show the consistency of the aims and the results of the study. Moreover, the authors discussed the results of the study comparing with the previous published studies. It may help the readers more clearly understanding. 9. The authors clearly described the implication for practice of the study. 10. The authors did not state the strengths and limitations of the study. Please state the strengths and limitations of the study. 11. The authors clearly presented conclusion and followed logically from the results of the study 12. The references that the authors cited in the text were published in the high standard journals in urogynecology field and had high relevance to the study which the authors interested in UI in the pregnant women. Moreover, most of references which the authors cited in the study were not over ten years. There were assumed that the knowledge from the previous published articles is not out of date. However, the authors please check the correct format of citations and references based on PLOS ONE. Reviewer #3: I have used the STROBE statement to guide my review (Vandenbroucke JP, Von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M, Strobe Initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med. 2007 Oct 16;4(10):e297.) Item 1a. study design not in title. Make it clear that the study investigates incontinence-specific QoL Item 1b. revise when comments addressed. Item 2. Does not make it clear that there is QoL (as an ‘overall’ concept) and incontinence-specific QoL. When you report QoL data in the introduction it is not clear which of these you refer to. Paragraph 5 of the introduction says there are limited reports of UI in pregnant women in Asia. This is insufficient. What is the body of evidence on this topic in a similar population? I note at least one publication in the reference list that is directly relevant. Why is a study needed? What can your study add? Item 3. Study objective not clearly phrased. Seems to imply only interested in QoL in incontinent women, but the study cohort is women with and without incontinence. This is also the place to make it clear that you are investigating incontinence specific QoL Items 7 and 8 and 11 and 16b. Please explain every variable (e.g. what are the sociodemographic and obstetric variables) and in what form the data were collected (e.g. date of birth), transformed (e.g. age at questionnaire completion) and categorised for analysis (e.g. dichotomisation into under 35 years of age, and 35 and over). Please also justify all categorisations (e.g. why 35?). Were all data self-reported including data such as gravidity and body weight and height (both of which you must have needed to calculate BMI) or were some data taken from the clinic record? Remember to discuss the accuracy of self-reported data (e.g. for weight/height) as this might influence your findings. The response categories on the ICIQ-LUTSQoL are ordinal yet the analysis seems is completed as if the data are continuous. Please explain/justify. Item 12c. Were there any missing data? If yes, explain how this was handled. If none, I think it is worth saying so. Item 13. What do you know about the women who did not take part (e.g. demographics? Reasons for non-participation?) Item 14. Table 1 presents the participant description by continence status (none, mild, moderate). Thus, there is no reporting of the descriptive data before it was categorised in some way. Item 16. The presentation of results in the text (the tables are generally good) lacks clarity throughout. For instance, the authors say “There was a clear association between the status of UI according to its severity and age, gravida, trimester, and vaginal delivery”. This tells me nothing about the direction of association, and UI status (e.g. is it younger or older age that is associated with having which UI severity?) And, in table 1 explain how the delivery mode data add up to n=440. If some of the women in this study are in their first pregnancy (n=170?) then they have not had a delivery yet. In tables 2 and 3 the mean difference and 95% CI for the difference is missing – p values are not sufficient. Without a mean difference and confidence interval it is very difficult to interpret this relative to the scoring of the QoL instrument. Why does table 2 not have delivery mode? Why are there a number of variables missing (e.g. age, education, etc) from table 3? This starts to appear like selective reporting. Why is age missing from the regression model? – based on table 2 it looks like it should be included. Items 18 to 21. Please address the study objective – clearly summarise the findings. For instance, ‘Non-Malay pregnant women, women in their second or third trimester, and women with stress UI, had greater odds of poor incontinence-specific quality of life. Variables not associated with worse incontinence-specific quality of life were…………………The most affected QoL domains were……” There is no discussion of any study limitations – what were they and what influence might they have on your findings? Please put the findings in the context of the data from other study on UI prevalence in pregnant women from Malaysia – what does your study add or confirm, and are there any inconsistencies and how might they be explained? Do the associations you find fit the pattern of associations others have found (or not)? How generalizable are these data? Most of the discussion about needs to inform women about various things irrelevant as your study objective is not about educating women or about interventions for UI. The implications for practice are not relevant to this study either. Only the first paragraph in the implications section could be considered appropriate – e.g. if it is common and affecting QoL then screening might be important – based on your data what can you say about who and how and when to find out if women have UI and what impact this is having for them? Minor editorial Introduction. Para 1. Last sentence. Reviews of what? Introduction. Para 6. Last sentence. Link between the two concepts (QoL, PFMT) not made clear. What do they have to do with each other? Design and respondent selection. Para 2. Mothers with. Not “mothers, those with”. And para 4. The word enumerators is not commonly used in English. Do you mean research assistants? And also in para 4, do you mean a woman could decline to participate or do you mean she could consent and then having consent withdraw? If women could withdraw once consented what happened to their data? Study instruments. Para 1. Last sentence - Do you adapted or adopted. If you adapted a measure in any way this must be explained fully and justified. Discussion. Don’t repeat data in the discussion. Reference. Multiple errors and inconsistencies. Needs thorough check. Cannot understand these sentences or phrases: Introduction. Para 5. First sentence. “the varieties of QOL reported minimum impact” Design and respondent selection. Para 4. “on voluntary purposes”. Results. Para 3. “All significant variables significantly associated role limitation and severity measures” Note, significantly is spelt incorrectly too. Results. Para 4. “Double protective risk of having poor QoL” ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
Revision 1 |
Quality of life among pregnant women with urinary incontinence: a cross-sectional study in a Malaysian primary care clinic. PONE-D-20-35389R1 Dear Dr. Mohd-Sidik, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Peter F.W.M. Rosier, M.D. PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #3: No ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The pilot study number of patients included for the validation of the questionnaire may not be adequate. However I feel if the statistician for Plos one can advise it may be still acceptable for the purpose of this publication. Otherwise I am satisfied with the corrections Reviewer #3: NONE FOR THE AUTHORS WHAT FOLLOWS IS A COMMENT FOR THE EDITORS. While I have said 'accept' and all comments were addressed I feel the manuscript does need an edit for language/grammar to meet the editorial standards of PLOS One. While the meaning of the revisions can be discerned because I know what reviewer questions/concerns they are responding to, it would be much more difficult for a PLOS One reader to grasp the meaning. None of the editing would require a subject expert. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #3: No |
Formally Accepted |
PONE-D-20-35389R1 Quality of life among pregnant women with urinary incontinence: a cross-sectional study in a Malaysian primary care clinic Dear Dr. Mohd-Sidik: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Peter F.W.M. Rosier Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .